Clinical Trial

Overactive Bladder Syndrome and Hypopressive Exercise

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 17, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
Overactive Bladder Syndrome (OAB) is a condition characterized by a sudden and urgent need to urinate, with or without urge incontinence, accompanied by increased urinary frequency. This syndrome significantly impacts individuals' social and economic lives, psychological well-being, work productivity, daily activities, and overall quality of life. The Abdominal Hypopressive Technique (AHT) was suggested by Caufriez for the treatment of pelvic floor disorders in women. It has been utilized in the treatment of pelvic floor dysfunctions, such as Urinary Incontinence (UI), particularly in postpartum women. A review of the existing literature reveals a lack of studies examining the relationship between overactive bladder syndrome and hypopressive exercises. Current research predominantly focuses on the effects of hypopressive exercises on pelvic organ prolapse, pelvic floor muscle tone, urinary incontinence, and stress urinary incontinence. Although AHT was initially developed for the treatment of pelvic floor disorders, it is now recommended for all women, regardless of the presence of UI. However, studies on AHT remain limited, which poses challenges for its broader scientific application. This highlights the need for robust scientific studies to strengthen the evidence base. The present study aims to evaluate the impact of an online hypopressive exercise training program on overactive bladder syndrome symptoms and quality of life. The main questions it aims to answer are: * Does online hypopressive exercise training effectively reduce the symptoms of overactive bladder syndrome? * Does online hypopressive exercise training effective in improving the quality of life among women with overactive bladder syndrome?
Trial Details
NCT Number NCT06780657
Lead Sponsor Pamukkale University
Conditions Overactive Bladder Syndrome
Enrollment 112 participants
Start Date 2024-08-30
Primary Completion 2025-09 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-01-17